Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Health Exchange Market (T.H.E.M.) was a Nashville-based healthcare technology company that specialized in the exchange and commercialization of de-identified healthcare data. Founded in 2017, the company operated an online marketplace designed to connect data providers with researchers and commercial entities, facilitating the valuation and negotiation of healthcare datasets. In 2020, the company expanded its offerings to include a COVID-19 Remote Patient Monitoring (RPM) solution and a point-of-care antibody testing platform integrated with Medicare billing systems. T.H.E.M. was notable for being ONC Certified in Health Data Exchange and CMS BlueButton 2.0 approved. Despite its diverse portfolio, which included the Orphan Disease Research Institute, the company is currently inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Health Exchange Market.